Edition:
United Kingdom

AnGes Inc (4563.T)

4563.T on Tokyo Stock Exchange

601JPY
15 Dec 2017
Change (% chg)

¥-10 (-1.64%)
Prev Close
¥611
Open
¥606
Day's High
¥622
Day's Low
¥600
Volume
1,431,400
Avg. Vol
2,950,928
52-wk High
¥884
52-wk Low
¥225

Latest Key Developments (Source: Significant Developments)

Anges MG says exercise of options
Tuesday, 23 May 2017 

May 23 (Reuters) - Anges MG Inc <4563.T>:* Says 9,000 units of its 29th series options were exercised to 900,000 shares of its common stock from May 1 to May 23.  Full Article

AnGes MG announces exercise of 10,300 options
Wednesday, 28 Sep 2016 

AnGes MG Inc <4563.T> :Says 10,300 of 28th warrants were exercised into 1.03 million shares of its common stock from Sept. 26 to Sept. 28, including 150,000 shares at exercise price 258 yen, 200,000 shares at 242 yen and 680,000 shares at 234 yen per share.  Full Article

AnGes MG announces exercise of 13,681 options
Friday, 23 Sep 2016 

AnGes MG Inc <4563.T> :Says 13,681 of 28th warrants were exercised into 1.37 million shares of its common stock from Sept. 16 to Sept. 23, including 150,000 shares at exercise price 209 yen and 200,000 shares at 206 yen etc..  Full Article

AnGes MG says exercise of warrants
Tuesday, 6 Sep 2016 

AnGes MG Inc <4563.T>:Says 7,800 of its 28th series warrants were exercised into 780,000 shares, during the period from Sep. 1 to Sep. 6.  Full Article

Anges MG announces exercise of options
Wednesday, 31 Aug 2016 

Anges MG Inc <4563.T>:Says 8,800 units of its 28th series options were exercised to 880,000 shares of its common stock from Aug. 23 to Aug. 30.  Full Article

Anges MG to work together with Vical Incorporated on DNA vaccine business
Friday, 12 Aug 2016 

Anges MG Inc <4563.T>:Says the company and Vical Incorporated has agreed to work together on DNA vaccine business, which includes research, development and manufacturing.  Full Article

AnGes MG to grant development manufacturing and marketing rights to Morishita Jintan
Thursday, 16 Jun 2016 

AnGes MG Inc <4563.T>: Says it reached basic agreement with Morishita Jintan Co Ltd <4524.T> on June 16 .Says it to grant exclusive development, manufacturing and marketing rights of cervical pre-cancer therapeutic vaccine to Morishita Jintan.  Full Article

AnGes MG announces exercise of warrants
Monday, 18 Apr 2016 

AnGes MG Inc:Says 64,367 of its 27th series warrants were exercised into 6,436,700 shares, during the period from April 12 to April 18.The shares exercised for 3,057,341,200 yen in total.  Full Article

AnGes MG announces exercise of warrants
Thursday, 14 Apr 2016 

AnGes MG Inc:Says 6,544 of its 27th series warrants were exercised into 654,400 shares at 435 yen per share, on April 14.  Full Article

AnGes MG announces exercise of warrants
Wednesday, 13 Apr 2016 

AnGes MG Inc:Says 20,000 of its 27th series warrants were exercised into 2,000,000 shares at 435 yen per share, on April 12.Says 30,000 of its 27th series warrants were exercised into 3,000,000 shares at 435 yen per share, on April 13.  Full Article

BRIEF-AnGes submits CTN of hypertension DNA vaccine

* Says it submitted Clinical Trial Notification (CTN) of hypertension DNA vaccine to Therapeutic Goods Administration (TGA) in Australia